Oral cavity squamous cell carcinoma is a painful and debilitating cancer. Another PET/CT after surgery and before adjuvant therapy could improve survival for these patients, according to a study published in the Journal of Nuclear Medicine.

Every week, Molecular Imaging brings hard-hitting neuroimaging research to light, but today we are highlighting the unorthodox work of one neuroscientist—his paintings, in fact, which depict the microstructure of the brain.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Robert E. Henkin Fellowship is an annual opportunity for nuclear medicine and molecular imaging professionals just starting out in their careers and are involved closely in government relations.

A protein called neurofibromin and a competing pathway could be the ticket to a novel gene therapy for a rare pediatric disorder called neurofibromatosis, which is associated with autism and learning difficulties. The proposed therapy could reverse these symptoms, announced officials from the University of Texas (UT) Southwestern on Monday.

Four generous grants from the U.S. Nuclear Regulatory Commission (NRC) have been bestowed on the Worcester Polytechnic Institute in Worcester, Mass., institute officials announced today.

PET/CT with Ga-68 DOTATATE has been found to change treatment plans in a majority of patients receiving initial evaluation and subsequent staging of neuroendocrine tumors (NETs), according to the results of two referring physician surveys published Dec. 11 in the Journal of Nuclear Medicine.

Reading a 3D thresholded SPECT vs. a conventional 2D SPECT has led to a dramatic improvement in sensitivity for the evaluation of attention deficit hyperactive disorder (ADHD), officials at Amen Clinics announced Dec. 9.

Definiens, the global leader in Tissue Phenomics® for oncology diagnostics, today announced the newest version of its leading image analysis software for quantitative digital pathology, Tissue Studio 4.0. The new release provides greater flexibility, more accurate and consistent results, and the ability to use any chromogen for single and dual stain immunohistochemistry (IHC) quantification.